Enzo Biochem, Inc.
ENZ
$0.464
-$0.015-3.13%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -193.96% | -228.54% | 198.15% | 192.41% | 191.46% |
| Total Depreciation and Amortization | -38.56% | -52.57% | -46.47% | -37.14% | -26.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.15% | 108.66% | -3,727.60% | -2,163.28% | -1,355.20% |
| Change in Net Operating Assets | -154.96% | -144.48% | -203.14% | -144.43% | 629.49% |
| Cash from Operations | 47.49% | 28.98% | -45.46% | -78.96% | -116.51% |
| Capital Expenditure | 68.71% | 80.25% | 61.07% | 44.72% | 23.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -95.71% | -100.55% | 4,041.51% | 285.41% | 287.71% |
| Total Debt Issued | -- | -- | 115.21% | -- | -- |
| Total Debt Repaid | 85.14% | 85.11% | -352.37% | -7,880.13% | -8,023.13% |
| Issuance of Common Stock | -- | -- | 2,657.14% | 1,328.57% | 1,328.57% |
| Repurchase of Common Stock | 63.60% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -150.32% | -272.71% | -259.79% | -430.99% | -454.84% |
| Foreign Exchange rate Adjustments | 116.83% | 95.41% | -455.56% | -664.71% | -20.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.29% | -151.02% | 287.82% | 5,954.41% | 830.04% |
